First multi-centre evaluation of a knowledge-based implant-assistant for implantable cardioverter-defibrillators.

نویسندگان

  • Bjoern Henrik Diem
  • Volker Lang
  • Anil Martin Sinha
  • Michael Mlynski
  • Christoph Stellbrink
  • Walter Ameling
  • Peter Hanrath
چکیده

AIMS Modern implantable cardioverter-defibrillators (ICDs) place increasing demands on the physician, as their complexity requires more and more knowledge and effort in handling them. To overcome this problem an implant-assistant has been developed, which transfers clinical data entered by the physician into a complete set of parameters for programming a dual-chamber ICD (Tachos-DR, Biotronik, Berlin, Germany) at DFT testing (DFT-Prog) and first permanent programming (Perm-Prog) after implant. METHODS AND RESULTS Routine ICD implantations were initially evaluated by clinical experts at 19 centres in USA and Europe from 178 patient files. The rating of parameters was related to the number of parameters available in each patient. For DFT-Prog, 98.4% of parameter suggestions were identical to experts' expectations, an additional 1.0% were accepted, 0.5% were rejected, and none was considered harmful. This resulted in an overall acceptance of 94.4% of the DFT-Prog. For Perm-Prog, 96.1% of parameters were identical to those advised by experts, an additional 2.4% were accepted, 1.5% rejected, and seven parameters (0.04%) were considered potentially harmful by experts with an overall acceptance of 86.5%. Adaptation of the implant-assistant increased the overall acceptance to 100% for DFT-Prog and 90.6% for first Perm-Prog without any potentially harmful suggestions. CONCLUSION The ICD implant-assistant, which allows the physician to programme ICDs directly from clinical data, is a promising method to simplify the programming of modern ICDs.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Survival of patients with implantable cardioverter defibrillators in the era of remote-monitoring: the 5000-foot, high-altitude view.

Large randomized trials have demonstrated unequivocally that implantable cardioverter defibrillators (ICDs) improve outcome for individuals with defined clinical characteristics known to be associated with a high risk of ventricular arrhythmias. However, less is known about outcomes of patients receiving ICDs in the “real world.” The National Cardiovascular Data Registry provides extensive and ...

متن کامل

Perioperative Management of Patients with Implantable Cardioverter Defibrillators

The first successful implant of an automated internal defibrillation system was described in 1980. Since then the number of indications for implantable cardioverter defibrillator (ICD) therapy has grown and the number of implants has risen rapidly. As a result, growing numbers of patients with ICD’s are presenting for surgery, potentially giving rise to uncertainty about device management, espe...

متن کامل

Implantable Cardioverter-Defibrillators in Children: Innovation to Design a Pediatric Implantable Cardioverter-Defibrillator

Although the implantable cardioverter-defibrillator (ICD) is now established as safe and effective for prevention of sudden cardiac death (SCD) in children, pediatrics accounts for less than 1% of market share, inhibiting corporate financial incentive for development of a pediatricspecific device. Over the past two decades since the ICD became clinically available, progressive downsizing of dev...

متن کامل

Routine exercise testing could not predict T‐wave oversensing in a patient after a subcutaneous implantable cardioverter‐defibrillator implant

Subcutaneous implantable cardioverter-defibrillators (S-ICDs) are susceptible to T-wave oversensing (TWOS) caused by high rate-dependent QRS-T morphology changes. We experienced an inappropriate S-ICD shock due to TWOS, which could not be predicted by routine exercise testing. A newly available high-pass filter might be effective for avoiding this.

متن کامل

Defibrillator Threshold Testing

Since implantable cardioverter-defibrillators (ICDs) were first introduced, defibrillator threshold (DFT) testing was considered an integral part of the implant procedure. Perform‐ ing DFT testing verifies the ability of the ICD in detecting and aborting the lethal arrhythmia it was designed to treat. The process has evolved with the development of the ICD’s and the expanding indications for th...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

دوره 8 3  شماره 

صفحات  -

تاریخ انتشار 2006